(DCO) Ducommun - Ratings and Ratios
Aircraft, Defense, Electronics, Satellites
DCO EPS (Earnings per Share)
DCO Revenue
Description: DCO Ducommun
Ducommun Incorporated (NYSE:DCO) is a US-based company operating in the Aerospace & Defense sub-industry. To evaluate its investment potential, we need to examine its financial health and key performance indicators.
The companys Income Tax Expense is a crucial aspect of its financials, as it directly impacts net income. Analyzing this expense on a yearly basis can provide insights into the companys tax strategy and potential future cash flows.
From a fundamental analysis perspective, Ducommuns Market Cap stands at $1.33 billion, with a P/E ratio of 38.45 and a Forward P/E of 26.11, indicating a potential decrease in earnings growth rate. The Return on Equity (RoE) is 5.21%, which is relatively low, suggesting that the company may not be generating sufficient profits from shareholder equity.
Key economic drivers for Ducommun include government defense spending, demand for commercial aircraft, and the overall health of the aerospace industry. The companys performance is likely tied to the US governments defense budget, as well as the demand for aerospace components and services.
To further assess Ducommuns investment potential, we should examine additional KPIs such as Revenue Growth, Operating Margin, and Debt-to-Equity ratio. A thorough analysis of these metrics can provide a more comprehensive understanding of the companys financial health and potential for future growth.
From a valuation perspective, we can compare Ducommuns P/E ratio to that of its industry peers to determine if the stock is overvalued or undervalued. Additionally, analyzing the companys historical financial performance and future guidance can help investors make informed decisions.
DCO Stock Overview
Market Cap in USD | 1,381m |
Sub-Industry | Aerospace & Defense |
IPO / Inception | 1973-05-03 |
DCO Stock Ratings
Growth Rating | 56.9 |
Fundamental | 54.1% |
Dividend Rating | 2.45 |
Rel. Strength | -1.49 |
Analysts | 4.60 of 5 |
Fair Price Momentum | 91.18 USD |
Fair Price DCF | 12.35 USD |
DCO Dividends
Currently no dividends paidDCO Growth Ratios
Growth Correlation 3m | 97.7% |
Growth Correlation 12m | 39.7% |
Growth Correlation 5y | 52.3% |
CAGR 5y | 17.88% |
CAGR/Max DD 5y | 0.47 |
Sharpe Ratio 12m | 1.06 |
Alpha | 24.75 |
Beta | 0.958 |
Volatility | 31.13% |
Current Volume | 127.3k |
Average Volume 20d | 129.7k |
Stop Loss | 87.2 (-4.8%) |
Signal | 0.00 |
Piotroski VR‑10 (Strict, 0-10) 5.0
Net Income (40.0m TTM) > 0 and > 6% of Revenue (6% = 47.7m TTM) |
FCFTA 0.04 (>2.0%) and ΔFCFTA 1.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 52.04% (prev 49.30%; Δ 2.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.05 (>3.0%) and CFO 55.5m > Net Income 40.0m (YES >=105%, WARN >=100%) |
Net Debt (219.2m) to EBITDA (71.1m) ratio: 3.08 <= 3.0 (WARN <= 3.5) |
Current Ratio 3.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (15.2m) change vs 12m ago 1.70% (target <= -2.0% for YES) |
Gross Margin 25.71% (prev 23.76%; Δ 1.95pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 69.98% (prev 68.61%; Δ 1.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 3.35 (EBITDA TTM 71.1m / Interest Expense TTM 13.7m) >= 6 (WARN >= 3) |
Altman Z'' 5.19
(A) 0.36 = (Total Current Assets 598.2m - Total Current Liabilities 184.5m) / Total Assets 1.14b |
(B) 0.42 = Retained Earnings (Balance) 476.5m / Total Assets 1.14b |
(C) 0.04 = EBIT TTM 45.9m / Avg Total Assets 1.14b |
(D) 1.12 = Book Value of Equity 484.2m / Total Liabilities 433.0m |
Total Rating: 5.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.05
1. Piotroski 5.0pt = 0.0 |
2. FCF Yield 2.57% = 1.28 |
3. FCF Margin 5.11% = 1.28 |
4. Debt/Equity 0.34 = 2.44 |
5. Debt/Ebitda 3.37 = -2.20 |
6. ROIC - WACC -4.09% = -5.11 |
7. RoE 5.82% = 0.48 |
8. Rev. Trend 81.12% = 4.06 |
9. Rev. CAGR 2.72% = 0.34 |
10. EPS Trend 33.45% = 0.84 |
11. EPS CAGR 6.38% = 0.64 |
What is the price of DCO shares?
Over the past week, the price has changed by +2.51%, over one month by +5.29%, over three months by +35.14% and over the past year by +41.97%.
Is Ducommun a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DCO is around 91.18 USD . This means that DCO is currently overvalued and has a potential downside of -0.46%.
Is DCO a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the DCO price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 106.3 | 16% |
Analysts Target Price | 81.4 | -11.1% |
ValueRay Target Price | 101.5 | 10.8% |
Last update: 2025-08-14 02:55
DCO Fundamental Data Overview
CCE Cash And Equivalents = 37.1m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 34.9208
P/E Forward = 26.8817
P/S = 1.737
P/B = 1.9511
P/EG = 3.339
Beta = 1.385
Revenue TTM = 795.1m USD
EBIT TTM = 45.9m USD
EBITDA TTM = 71.1m USD
Long Term Debt = 218.1m USD (from longTermDebt, last quarter)
Short Term Debt = 21.4m USD (from shortTermDebt, last quarter)
Debt = 239.4m USD (Calculated: Short Term 21.4m + Long Term 218.1m)
Net Debt = 219.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.58b USD (1.38b + Debt 239.4m - CCE 37.1m)
Interest Coverage Ratio = 3.35 (Ebit TTM 45.9m / Interest Expense TTM 13.7m)
FCF Yield = 2.57% (FCF TTM 40.6m / Enterprise Value 1.58b)
FCF Margin = 5.11% (FCF TTM 40.6m / Revenue TTM 795.1m)
Net Margin = 5.03% (Net Income TTM 40.0m / Revenue TTM 795.1m)
Gross Margin = 25.71% ((Revenue TTM 795.1m - Cost of Revenue TTM 590.7m) / Revenue TTM)
Tobins Q-Ratio = 3.27 (Enterprise Value 1.58b / Book Value Of Equity 484.2m)
Interest Expense / Debt = 1.26% (Interest Expense 3.01m / Debt 239.4m)
Taxrate = 14.66% (from yearly Income Tax Expense: 5.41m / 36.9m)
NOPAT = 39.2m (EBIT 45.9m * (1 - 14.66%))
Current Ratio = 3.24 (Total Current Assets 598.2m / Total Current Liabilities 184.5m)
Debt / Equity = 0.34 (Debt 239.4m / last Quarter total Stockholder Equity 707.8m)
Debt / EBITDA = 3.37 (Net Debt 219.2m / EBITDA 71.1m)
Debt / FCF = 5.89 (Debt 239.4m / FCF TTM 40.6m)
Total Stockholder Equity = 687.2m (last 4 quarters mean)
RoA = 3.50% (Net Income 40.0m, Total Assets 1.14b )
RoE = 5.82% (Net Income TTM 40.0m / Total Stockholder Equity 687.2m)
RoCE = 5.07% (Ebit 45.9m / (Equity 687.2m + L.T.Debt 218.1m))
RoIC = 4.21% (NOPAT 39.2m / Invested Capital 930.3m)
WACC = 8.30% (E(1.38b)/V(1.62b) * Re(9.55%)) + (D(239.4m)/V(1.62b) * Rd(1.26%) * (1-Tc(0.15)))
Shares Correlation 5-Years: 100.0 | Cagr: 4.45%
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.19% ; FCFE base≈34.7m ; Y1≈23.9m ; Y5≈12.1m
Fair Price DCF = 12.35 (DCF Value 184.3m / Shares Outstanding 14.9m; 5y FCF grow -36.37% → 3.0% )
Revenue Correlation: 81.12 | Revenue CAGR: 2.72%
Revenue Growth Correlation: -57.71%
EPS Correlation: 33.45 | EPS CAGR: 6.38%
EPS Growth Correlation: 42.01%
Additional Sources for DCO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle